Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Dec 02 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

Please find enclosed a copy of press release dated December 2, 2022 titled Zydus receives final approval from the USFDA for Estradiol Transdermal System which will be manufactured at the Moraiya plant���.

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases